DZ2002 ocysteine (SAH) Wiegering A

Wiegering A

Rociletinib

is a diaminopyrimidine compound that induces the differentiation of MHC- (myosin heavy chain) positive cardiomyocytes from embryonic stem cells with an EC50 value of 0

is noted to have a higher IC50 value of 70

DZ2002 ocysteine (SAH) Wiegering ADZ 2002 is a potent reversible inhibitor of S adenosyl L homocysteine hydrolase (SAHH). DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models. DZ2002 prevents the development of experimental dermal fibrosis by reversing the profibrotic phenotype of various cell types and would be a potential drug for the treatment of systemic sclerosis. Product information CAS Number: 33231 14 0 Molecular Weight: 251. 24